Skip to main content
PolicySpeak
← All files
KWS

KWS

Company · Germany · EU Transparency Register 106034119290-26

2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #443 by legislative files engaged — a count of participation, not a measure of influence.

1.4
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2015
in the register since

Declares membership of

  • www.euroseeds.org
  • www.plantetp.org

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Registered as
KWS SAAT SE & Co. KGaA (KWS)
Head office
Einbeck, Germany

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track KWS in PolicySpeak: request access →

Work at KWS? so we know who speaks for it.

Follow the files KWS engages with

One email on Tuesdays when a new position is filed on these 2 files, from KWS or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

KWS filed 2 positions between 13 Mar 2025 and 10 Jun 2026, across 2 of the 326 legislative files tracked here.

2025 · 1 filed2026 · 1 filed

What they argued

Biotech Act IIfiled 10 Jun 2026source

KWS welcomes the European Commissions intention to develop a European Biotech Act II. This initiative represents a key opportunity to strengthen Europes competitiveness, technological sovereignty, and resilience, while accelerating the transition to a sustainable bioeconomy.

Evaluation of the EU legislation on plant variety rightsfiled 13 Mar 2025source

KWS, as a leading German plant breeding company, welcomes and supports the EU Commissions initiative on the evaluation of the EU legislation on community plant variety rights (CPVR) as an important means to ensure that the EU legal framework continues to foster innovation and safeguard intellectual property in the plant breeding sector.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 7.

Is this your organization?

Everything on this page comes from KWS’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.